MetaCap

The Pennant Group Inc. (PNTG)

NASDAQ: PNTGHealth CareMedical/Nursing ServicesUSD

34.64+0.55 (+1.61%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

PNTG stock chart

Technical analysis

Key statistics

All statistics
52-week range
26.40 – 44.24
Day range
34.06 – 34.97
Volume / Avg
444.53K / 391.52K
Beta
—

52-week range

$26.40$44.24

PNTG stock today

Shares of Pennant Group (PNTG) finished higher on Nov 20 at $34.64, a gain of 1.61% or $0.55 per share, versus the S&P 500's 3.70% decline. Shares are 21.7% below their 52-week high of $44.24, set on Nov 4, 2026 and 31.2% above the 52-week low of $26.40, in the middle of the past year's range. PNTG is up 23.1% year to date, outperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 29.9%.

At 34.3x trailing earnings, Pennant Group trades above the peer-group median of 29.7x. Its forward P/E of 22.0x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year.

Summary generated from market data by MetaCap's automated system. Methodology

About Pennant Group

Company profile

The Pennant Group, Inc. provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services.

Industry
Medical/Nursing Services
CEO
Mr. Brent J. Guerisoli
Headquarters
Eagle, ID
Employees
9,700

Financial highlights

Full financials

In fiscal 2025, Pennant Group generated $947.7 million in revenue, up 36.3% from fiscal 2024, its 8th consecutive year of revenue growth. Net income was $29.6 million (+31.1% year over year), for a net margin of 3.1% versus a median of 2.5% in the prior 5 years. Gross margin was 18.9% (down from 19.7%) and operating margin 5.5%.

Pennant Group annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue$947.71M$695.24M$544.89M$473.24M$439.69M
Growth+36.31%+27.59%+15.14%+7.63%+12.47%
Net income$29.58M$22.56M$13.38M$6.64M$2.70M
EPS (diluted)$0.84$0.70$0.44$0.22$0.09

Analyst forecast

Forecast

Consensus (7 analysts)

strong_buy

Avg. price target

$48.00+38.57%

  • Strong buy 1
  • Buy 6
  • Hold 0
  • Sell 0
  • Strong sell 0

Target range

Low $46.00High $50.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Nov 4, 2026
EPS actual vs est.
$0.26 vs $0.28
Surprise
-7.14%

PNTG news

All PNTG news

Pennant Group peers

Health Care sector
PNTG peer companies
CompanyPrice% ChgMarket capCompare
INNVInnovAge Holding Corp.9.16+2.81%$1.25Bvs PNTG
TDOCTeladoc Health Inc.7.45-4.36%$1.36Bvs PNTG
WGSGeneDx Holdings Corp. Class A45.46-7.68%$1.36Bvs PNTG
AHCOAdaptHealth Corp.7.20-0.69%$982.98Mvs PNTG
USPHU.S. Physical Therapy Inc.95.93+1.71%$1.43Bvs PNTG
OMDAOmada Health Inc.11.87-5.04%$736.39Mvs PNTG
SBCSBC Medical Group Holdings Incorporated5.17-7.68%$530.32Mvs PNTG
SRTAStrata Critical Medical Inc. Class A4.56-5.59%$407.30Mvs PNTG

Indexes, lists and sector

Pennant Group stock FAQ

What is Pennant Group's stock price today?

PNTG last traded at $34.64 as of Nov 20, 4:00 PM EST, up 1.61% on the day. Prices are delayed at least 15 minutes.

What is PNTG's P/E ratio?

PNTG trades at a trailing P/E ratio of 34.30 and a forward P/E of 22.00, compared with a median of 29.7 for its closest peers.

Who is Pennant Group's CEO?

Mr. Brent J. Guerisoli is the chief executive officer of The Pennant Group Inc., which has about 9,700 employees.

What is the PNTG 52-week high?

The 52-week high for PNTG is $44.24 and the 52-week low is $26.40. The stock is currently 21.7% below its high.

Compare PNTG